Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11590128 | Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more | 2023-02-28 |
| 11413282 | Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Christian Klein, Wayne Fairbrother | 2022-08-16 |
| 11110087 | Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor | Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more | 2021-09-07 |
| 10993942 | Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more | 2021-05-04 |
| 10959993 | Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer | Mark Merchant, Marina Konopleva, Lina Han | 2021-03-30 |
| 10898570 | Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor | Gail Lewis Phillips, Ingrid Wertz | 2021-01-26 |
| 10092567 | Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use | Kui Lin, Michelle Nannini, Elizabeth Punnoose, Jeffrey Wallin, Premal Patel | 2018-10-09 |
| 9855270 | Methods and compositions for modulating estrogen receptor mutants | Jeffrey J. Hager, James D. Joseph, Jing Qian, Nicholas D. Smith, Edna Chow Maneval +2 more | 2018-01-02 |
| 9717730 | Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use | Kui Lin, Michelle Nannini, Elizabeth Punnoose, Jeffrey Wallin, Premal Patel | 2017-08-01 |
| 9682082 | Combinations of AKT and MEK inhibitor compounds, and methods of use | Brian Lee, Kui Lin, Michelle Nannini, Elizabeth Punnoose | 2017-06-20 |
| 9610289 | Combinations of AKT inhibitor compounds and erlotinib, and methods of use | Michelle Nannini | 2017-04-04 |
| 9539251 | Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor | Christian Klein, Wayne Fairbrother | 2017-01-10 |
| 9346789 | Combinations of AKT inhibitor compounds and abiraterone, and methods of use | Michelle Nannini | 2016-05-24 |
| 9150549 | Combinations of AKT inhibitor compounds and erlotinib, and methods of use | Michelle Nannini | 2015-10-06 |
| 9107926 | Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer | Marcia Belvin, Lori Friedman, Jeffrey Wallin | 2015-08-18 |
| 8604014 | Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use | Marcia Belvin, Lori Friedman, Klaus Hoeflich, Ulka Vijapurkar, Jeffrey Wallin +3 more | 2013-12-10 |
| 8247397 | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use | Marcia Belvin, Lori Friedman, Klaus Hoeflich, Ulka Vijapurkar, Jeffrey Wallin +3 more | 2012-08-21 |